References
- Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology. 2020;95(2):77-84. DOI: 10.1212/WNL.0000000000009673
- Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin rheumatol. 2020;39(7):2055-62. DOI: 10.1007/s10067-020-05073-9
- Garg Y, Kakria N, Singh S, Jindal AK. Coronavirus disease-19 triggered systemic lupus erythematous: A novel entity. Lung India: Official Organ of Indian Chest Society. 2023;40(1):79. DOI: 10.4103/lungindia.lungindia_494_21
- Danchenko N, Satia J, Anthony M. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308-18. DOI: 10.1191/0961203306lu2305xx
- Sène D, Piette J-C, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun rev. 2008;7(4):272-7. DOI: 10.1016/j.autrev.2007.10.001
- Aringer M, Costenbader KH, Dörner T, Johnson SR. Gastrointestinal SLE involvement in SLE classification. Response to: “2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al” by Cui et al. Annals of the Rheumatic Diseases. 2020. DOI: 10.1136/annrheumdis-2020-218615
- Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb;4(2):295-306. DOI: 10.1111/j.1538-7836.2006.01753.x
- Kouranloo K, Dey M, Elwell H, Nune A. A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatol int. 2023:1-23. DOI: 10.1007/s00296-023-05283-9
- Wucherpfennig KW. Structural basis of molecular mimicry. J autoimmun. 2001;16(3):293-302. DOI: 10.1006/jaut.2000.0499
- Vahabi M, Ghazanfari T, Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int Immunopharmacol. 2022:109183. DOI: 10.1016/j.intimp.2022.109183
- Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine. 2008;87(6):311-8. DOI: 10.1097/MD.0b013e31818ec711
- Regner M, Lambert P-H. Autoimmunity through infection or immunization? Nature immunol. 2001;2(3):185-8. DOI: 10.1038/85228
- Uthman IW, Gharavi AE, editors. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum. 2002 Feb;31(4):256-63. DOI: 10.1053/sarh.2002.28303
- Homa T, Abrahim S, Uzma H, Adler B, Law G, Kirthi M, et al. Fevers in Adult Lupus Patients. Cureus. 2018;10(1).
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis rheumatol. 2019;71(9):1400-12. DOI: 10.1002/art.40930
- Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. New England J Med. 2002;346(10):752-63. DOI: 10.1056/NEJMra002974
- Asherson R, Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis. 2003 May;62(5):388-393. DOI: 10.1136/ard.62.5.388
- Vila P, Hernandez M, Lopez-Fernandez M, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost. 1994 Aug;72(2):209-13. DOI: 10.1055/s-0038-1648840
- Pineton de Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, Mathian A, Hekimian G, Combes A. High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? J Intern Med. 2021 Mar;289(3):422-424. DOI: 10.1111/joim.13126
- Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40. DOI: 10.1182/blood.2020006000
- Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891. DOI: 10.1136/jnnp-2020-323586
- Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):e38. DOI: 10.1056/NEJMc2007575
- Gemcioglu E, Erden A, Davutoglu M, Karabuga B, Kucuksahin O. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19. J Clin Rheumatol. 2020 Sep;26(6):236-237. DOI: 10.1097/RHU.0000000000001565